Donckels Elizabeth A, Cunniff Luke, Regenold Nina, Esselman Kaitlyn, Muther Erik, Bhatti Alexandra, Eiden Amanda L
Real Chemistry Market Access, San Francisco, CA 94108, USA.
Merck & Co., Inc., Rahway, NJ 07065, USA.
Vaccines (Basel). 2023 Jul 15;11(7):1242. doi: 10.3390/vaccines11071242.
The COVID-19 pandemic has focused attention on the use of immunization information systems (IIS) to record and consolidate immunization records from a variety of sources to generate comprehensive patient immunization histories. Operationalization of IIS in the United States is decentralized, and as such, there are over 60 different IIS with wide variations in enabling policies and functionalities. As such, the policies that inform the development and operation of those sub-national IIS exist at the state and sometimes city levels. A targeted literature review was conducted to identify IIS policies and functionalities and assess their impact. The authors identified articles published from 2012 to 2022 that discussed or evaluated IIS policies and functionalities and screened titles, abstracts, and full text for inclusion. When selected for inclusion, authors extracted IIS policy/functionality characteristics and qualitative or quantitative outcomes of their implementation, where applicable. The search terms yielded 86 articles, of which 39 were included in the analysis. The articles were heterogeneous with respect to study design, interventions, outcomes, and effect measures. Out of the 17 IIS policies and functional components identified in the targeted literature review, the most commonly evaluated were provider-based patient reminder/recall, IIS-based centralized reminder/recall, and clinical decision support. Patient reminder/recall had the most published research and was associated with increased vaccination rates and vaccine knowledge. Despite the lack of quantitative evidence, there is a consensus that immunization data interoperability is critical to supporting IIS data quality, access, and exchange. Significant evidence gaps remain about the effectiveness of IIS functionalities and policies. Future research should evaluate the impact of policies and functionalities to guide improved utilization of IIS, increase national interoperability and standardization, and ultimately improve vaccination coverage and population health.
新冠疫情使人们将注意力集中在免疫信息系统(IIS)的使用上,该系统用于记录和整合来自各种来源的免疫记录,以生成全面的患者免疫史。美国免疫信息系统的运营是分散的,因此有60多种不同的免疫信息系统,其启用政策和功能差异很大。因此,指导这些地方层面免疫信息系统开发和运营的政策存在于州一级,有时也存在于城市层面。我们进行了有针对性的文献综述,以确定免疫信息系统的政策和功能,并评估其影响。作者筛选了2012年至2022年发表的讨论或评估免疫信息系统政策和功能的文章,并对标题、摘要和全文进行筛选以确定是否纳入。入选后,作者提取了免疫信息系统政策/功能特征及其实施的定性或定量结果(如适用)。搜索词共产生86篇文章,其中39篇纳入分析。这些文章在研究设计、干预措施、结果和效果测量方面存在异质性。在有针对性的文献综述中确定的17项免疫信息系统政策和功能组件中,评估最多的是基于提供者的患者提醒/召回、基于免疫信息系统的集中提醒/召回和临床决策支持。患者提醒/召回方面发表的研究最多,并且与疫苗接种率和疫苗知识的增加相关。尽管缺乏定量证据,但人们一致认为免疫数据的互操作性对于支持免疫信息系统的数据质量、访问和交换至关重要。关于免疫信息系统功能和政策的有效性,仍存在重大证据空白。未来的研究应评估政策和功能的影响,以指导免疫信息系统的更好利用,提高国家层面的互操作性和标准化,并最终提高疫苗接种覆盖率和人群健康水平。